Clinical trials
Enrolling by invitation Hyperlipoproteinemia Type II trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Geisinger Clinic | 1 |
| Karolinska Institutet | 1 |
| LIB Therapeutics LLC | 1 |
| Northwestern University | 1 |
| Tung Wah College | 1 |
| Verve Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipoproteinemia Type II | 6 |
| Hypercholesterolemia | 3 |
| Cardiovascular Diseases | 2 |
| Anxiety Disorders | 1 |
| Atherosclerosis | 1 |
| Coronary Artery Disease | 1 |
| Ischemic Stroke | 1 |
| Peripheral Arterial Disease | 1 |
Trials
Showing 26 to 6 of 6. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.